Life Sciences Denver Market Analysis (Cushman & Wakefield Insight)
The hypergrowth experienced by the life sciences sector early in the pandemic has given way to a much more normalized environment today— with funding in the life sciences space having declined 26% year-over-year (YoY), according to Cushman & Wakefield’s September Life Sciences Update. As firms’ growth trajectories have softened, so has the life sciences lab market with hiring […]
Life Sciences Denver Market Analysis (Cushman & Wakefield Insight) Read More »










